Table 2.
Treatment Outcome group | Baseline(O) | WAZ values 24 wks | 48 wks | P |
---|---|---|---|---|
VS/IS (n = 75)# | ||||
WAZ mean (SD) | -1.07 (1.3) | -0.05 (1.4) | 0.50 (1.2) | < 0.0001* |
VS/IF (n = 21) | ||||
WAZ mean (SD) | -1.84 (1.3) | -1.02 (1.3) | - 0.41 (1.2) | 0.002 |
VF/IS (n = 10) | ||||
WAZ mean(SD) | -0.98 (1.7) | 0.44 (1.5) | 1.22 (1.5) | 0.013 |
VF/IF (n = 6) | ||||
WAZ mean (SD) | -0.70 (0.63) | 0.37 (0.76) | 0.97 (0.8) | 0.004 |
†12 missing WAZ values were > 10 yrs *ANOVA, statistically significant at the 0.05 alpha level. #n = 75, 71 & 69 at 0, 24 and 48 weeks respectively. WAZ = Weight for Age z score. VS = virological success, VF = virological failure, VF = virological failure and IF = immunological failure.